Study | Reason for exclusion |
---|---|
EBMTR | Insufficient information on baseline characteristics (less than 5 factors without substantial missing data). Insufficient information on treatment plan, already apparent imbalances between use of TBI in the "planned" or "unplanned" group. |
Kim 2009 | No separate information on patients receiving either one or two transplants. |
Koren 2010 | No separate information on patients receiving either one or two transplants. |
Lahuerta 2003 | No separate information on patients receiving either one or two transplants. |
NMSG | Insufficient information on baseline characteristics (less than 5 factors). Insufficient information on treatment plan. |
Sonneveld 2007 | Non‐myeloablative dosing regimen of melphalan (2 x 70 mg/m²). |
Total therapy | No RCT. No contemporary control group. Of note: integration of novel agents in TT generation >1 is regarded as a critically different treatment approach compared to the set of included RCTs. |